Articles

A survey of laboratory professionals led by ARUP experts clarified factors that contribute to the success of laboratory stewardship programs.

In a new letter to the editor of JAMA, ARUP leaders discuss how ongoing regulatory challenges may hinder laboratory-developed test innovation.

ARUP Consult, a free source of expert guidance in laboratory testing, offers valuable information on relevant topics from monkeypox to HLA testing and more.

Forbes Magazine has recognized the support ARUP offers women as they build their careers by naming ARUP as one of America’s Best Employers for Women.

ARUP has launched a new, in-house test to detect the DNA of orthopoxviruses, including monkeypox.

The Summer 2022 edition of Magnify, now online, features a look at the challenges of autoimmune neurologic testing, our experts in this area, and recent awards, and catches up with a former fellow.

ARUP medical directors and scientists will share their research and expertise in areas like lab stewardship, biochemical genetics, and neonatal drug testing at AACC’s 2022 annual meeting in Chicago.

Scientist Michael T. Pyne shares ARUP’s challenges and process of developing a next generation sequencing (NGS) test for HIV-1 antiretroviral drug resistance.

ARUP Consult, a free source of expert guidance in laboratory testing, has released new and updated resources on testing for immunobullous diseases, diabetes mellitus, and prostate cancer.

ARUP offers several antibody panels to test for immunobullous diseases, which are difficult to diagnose. The Immunobullous Disease Testing Comparison tool allows users to quickly compare test options.

ARUP experts say that the VALID Act, which would require FDA approval of all lab-developed tests, would add administrative and financial burdens to an already safe and effective validation process.

ARUP Laboratories invites medical professionals to participate in a free webinar that will feature creative solutions to address the current laboratory and hospital staffing crisis.